# Link Validation Report

Generated: 2026-01-17T05:10:38.098Z

**Script:** `scripts/validate-links-and-images.ts`

## Summary

- **Total links/images checked:** 2983
- ✅ **OK:** 2618
- ⚠️ **Warnings (401/403):** 202
- ❌ **Broken:** 1
- ⏱️ **Timeouts:** 1
- ⚠️ **Errors (not in archive.org):** 3

## Broken Links/Images

### interventions\dimethyl-sulfoxide-dmso.md

- [ ] **LINK** [https://core.ac.uk/download/pdf/38907515.pdf](https://core.ac.uk/download/pdf/38907515.pdf) - Status: 404 (line 120)

## Timeout URLs

### reference\automatic-pill-dispensers.md

- [ ] **LINK** [https://www.lifeline.philips.com/business/medicationdispensing](https://www.lifeline.philips.com/business/medicationdispensing) (line 94)

## Warning URLs (401/403 - May require authentication)

### solution.md

- [ ] **LINK** [https://publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/4207.htm](https://publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/4207.htm) - Status: 403 (line 182)
- [ ] **LINK** [https://publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/4207.htm](https://publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/4207.htm) - Status: 403 (line 182)

### problem.md

- [ ] **LINK** [https://www.clinicalresearch.io/blog/industry-trends/cost-of-clinical-trials-breakdown/](https://www.clinicalresearch.io/blog/industry-trends/cost-of-clinical-trials-breakdown/) - Status: 403 (line 35)
- [ ] **LINK** [https://www.fiercehealthcare.com/mobile/mobile-health-app-development-costs-425-000-on-average](https://www.fiercehealthcare.com/mobile/mobile-health-app-development-costs-425-000-on-average) - Status: 403 (line 110)
- [ ] **LINK** [https://www.fiercehealthcare.com/mobile/mobile-health-app-development-costs-425-000-on-average](https://www.fiercehealthcare.com/mobile/mobile-health-app-development-costs-425-000-on-average) - Status: 403 (line 113)
- [ ] **LINK** [https://www.centerwatch.com/articles/12702-new-mit-study-puts-clinical-research-success-rate-at-14-percent](https://www.centerwatch.com/articles/12702-new-mit-study-puts-clinical-research-success-rate-at-14-percent) - Status: 403 (line 167)

### logical-proof.md

- [ ] **LINK** [https://www.evidera.com/rare-disease-treatments-arent-so-rare-any-more/](https://www.evidera.com/rare-disease-treatments-arent-so-rare-any-more/) - Status: 403 (line 11)
- [ ] **LINK** [https://www.gavi.org/vaccineswork/inside-story-recovery-how-worlds-largest-covid-19-trial-transformed-treatment-and](https://www.gavi.org/vaccineswork/inside-story-recovery-how-worlds-largest-covid-19-trial-transformed-treatment-and) - Status: 403 (line 13)
- [ ] **LINK** [https://www.evidera.com/rare-disease-treatments-arent-so-rare-any-more/](https://www.evidera.com/rare-disease-treatments-arent-so-rare-any-more/) - Status: 403 (line 103)
- [ ] **LINK** [https://www.gavi.org/vaccineswork/inside-story-recovery-how-worlds-largest-covid-19-trial-transformed-treatment-and](https://www.gavi.org/vaccineswork/inside-story-recovery-how-worlds-largest-covid-19-trial-transformed-treatment-and) - Status: 403 (line 107)

### home.md

- [ ] **LINK** [https://player.vimeo.com/video/930843979?badge=0&amp;autopause=0&amp;player_id=0&amp;app_id=58479](https://player.vimeo.com/video/930843979?badge=0&amp;autopause=0&amp;player_id=0&amp;app_id=58479) - Status: 401 (line 131)
- [ ] **LINK** [https://www.fiercebiotech.com/biotech/drug-development-cost-pharma-22b-asset-2024-plus-how-glp-1s-impact-roi-deloitte](https://www.fiercebiotech.com/biotech/drug-development-cost-pharma-22b-asset-2024-plus-how-glp-1s-impact-roi-deloitte) - Status: 403 (line 232)

### architecture.md

- [ ] **LINK** [https://github.com/cure-dao/docs/blob/main/reference-databases/units/ucum_units_of_measure.csv](https://github.com/cure-dao/docs/blob/main/reference-databases/units/ucum_units_of_measure.csv) - Status: 429 (line 166)

### strategy\executive-action-implementation.md

- [ ] **LINK** [https://officeofbudget.od.nih.gov/](https://officeofbudget.od.nih.gov/) - Status: 403 (line 132)

### regulatory\dfda-executive-order.md

- [ ] **LINK** [https://www.congress.gov/bill/114th-congress/house-bill/34](https://www.congress.gov/bill/114th-congress/house-bill/34) - Status: 403 (line 183)

### reference-databases\supplement-databases.md

- [ ] **LINK** [https://dsld.od.nih.gov/](https://dsld.od.nih.gov/) - Status: 403 (line 7)
- [ ] **LINK** [https://dietarysupplementdatabase.usda.nih.gov/](https://dietarysupplementdatabase.usda.nih.gov/) - Status: 403 (line 12)
- [ ] **LINK** [https://s3.amazonaws.com/static.quantimo.do/unified-health-api/reference-databases/supplements/DSLD-full-database-JSON.zip](https://s3.amazonaws.com/static.quantimo.do/unified-health-api/reference-databases/supplements/DSLD-full-database-JSON.zip) - Status: 403 (line 18)
- [ ] **LINK** [https://s3.amazonaws.com/static.quantimo.do/unified-health-api/reference-databases/supplements/Dietary%20Supplement%20Label%20Database/all\_lstIngredients\_csv.zip](https://s3.amazonaws.com/static.quantimo.do/unified-health-api/reference-databases/supplements/Dietary%20Supplement%20Label%20Database/all\_lstIngredients\_csv.zip) - Status: 403 (line 19)
- [ ] **LINK** [https://s3.amazonaws.com/static.quantimo.do/unified-health-api/reference-databases/supplements/Dietary%20Supplement%20Label%20Database/all\_lstProducts\_csv.zip](https://s3.amazonaws.com/static.quantimo.do/unified-health-api/reference-databases/supplements/Dietary%20Supplement%20Label%20Database/all\_lstProducts\_csv.zip) - Status: 403 (line 20)

### reference-databases\monoamine-oxidase-inhibitors-maois.md

- [ ] **LINK** [https://maoinhibitors.com/](https://maoinhibitors.com/) - Status: 403 (line 44)
- [ ] **LINK** [https://maoinhibitors.com/](https://maoinhibitors.com/) - Status: 403 (line 391)

### reference-databases\blood-pressure.md

- [ ] **LINK** [https://www.heart.org/en/health-topics/high-blood-pressure/understanding-blood-pressure-readings/hypertensive-crisis-when-you-should-call-911-for-high-blood-pressure](https://www.heart.org/en/health-topics/high-blood-pressure/understanding-blood-pressure-readings/hypertensive-crisis-when-you-should-call-911-for-high-blood-pressure) - Status: 403 (line 52)

### reference-databases\biomarker-databases.md

- [ ] **LINK** [https://s3.amazonaws.com/static.quantimo.do/unified-health-api/reference-databases/Loinc\_2.71.zip](https://s3.amazonaws.com/static.quantimo.do/unified-health-api/reference-databases/Loinc\_2.71.zip) - Status: 403 (line 10)
- [ ] **LINK** [https://s3.amazonaws.com/static.quantimo.do/unified-health-api/reference-databases/Loinc\_2.71\_LoincTableCore.zip](https://s3.amazonaws.com/static.quantimo.do/unified-health-api/reference-databases/Loinc\_2.71\_LoincTableCore.zip) - Status: 403 (line 11)
- [ ] **LINK** [https://s3.amazonaws.com/static.quantimo.do/unified-health-api/reference-databases/Loinc\_2.71\_Text\_2.71.zip](https://s3.amazonaws.com/static.quantimo.do/unified-health-api/reference-databases/Loinc\_2.71\_Text\_2.71.zip) - Status: 403 (line 12)

### reference\tyramine-avoidance-diet.md

- [ ] **LINK** [https://prd-medweb-cdn.s3.amazonaws.com/documents/neurology/files/Tyramine%20Menu%20Book%2006227101.pdf](https://prd-medweb-cdn.s3.amazonaws.com/documents/neurology/files/Tyramine%20Menu%20Book%2006227101.pdf) - Status: 403 (line 8)

### reference\references.md

- [ ] **LINK** [https://www.fdareview.org/issues/theory-evidence-and-examples-of-fda-harm/](https://www.fdareview.org/issues/theory-evidence-and-examples-of-fda-harm/) - Status: 403 (line 4)
- [ ] **LINK** [https://delong.typepad.com/print/20061012_LRWGDP.pdf](https://delong.typepad.com/print/20061012_LRWGDP.pdf) - Status: 403 (line 9)
- [ ] **LINK** [https://www.amplion.com/report-suggests-drug-approval-rate-now-just-1-in-10/](https://www.amplion.com/report-suggests-drug-approval-rate-now-just-1-in-10/) - Status: 403 (line 11)
- [ ] **LINK** [https://www.fdareview.org/issues/reform-options/](https://www.fdareview.org/issues/reform-options/) - Status: 403 (line 21)

### reference\public-money-public-code-initiative.md

- [ ] **LINK** [https://www.srijan.net/blog/open-source-vs-proprietary-software-which-one-is-more-secure](https://www.srijan.net/blog/open-source-vs-proprietary-software-which-one-is-more-secure) - Status: 403 (line 154)

### reference\pragmatic-trials.md

- [ ] **LINK** [https://www.anjusoftware.com/insights/eclinical/clinical-trial-costs/](https://www.anjusoftware.com/insights/eclinical/clinical-trial-costs/) - Status: 403 (line 17)

### reference\open-source-food-projects.md

- [ ] **LINK** [https://www.foodrepo.org/](https://www.foodrepo.org/) - Status: 403 (line 15)

### reference\measuring-cognitive-performance.md

- [ ] **LINK** [https://www.dementia.org/diagnosing-dementia-the-montreal-cognitive-assessment](https://www.dementia.org/diagnosing-dementia-the-montreal-cognitive-assessment) - Status: 403 (line 82)

### reference\impact-of-innovative-medicines-on-life-expectancy.md

- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/assets/disease-causing-death-shift.gif](https://static.crowdsourcingcures.org/dfda/assets/disease-causing-death-shift.gif) - Status: 403 (line 4)
- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/assets/disease-causing-death-shift.gif](https://static.crowdsourcingcures.org/dfda/assets/disease-causing-death-shift.gif) - Status: 403 (line 4)
- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/assets/more-surviving-more-therapies.gif](https://static.crowdsourcingcures.org/dfda/assets/more-surviving-more-therapies.gif) - Status: 403 (line 8)
- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/assets/more-surviving-more-therapies.gif](https://static.crowdsourcingcures.org/dfda/assets/more-surviving-more-therapies.gif) - Status: 403 (line 8)

### reference\historical-evidence-supporting-real-wold-efficacy-trials.md

- [ ] **LINK** [https://publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/4207.htm](https://publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/4207.htm) - Status: 403 (line 58)
- [ ] **LINK** [https://publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/4207.htm](https://publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/4207.htm) - Status: 403 (line 58)

### reference\historical-evidence-supporting-decentralized-efficacy-trials.md

- [ ] **LINK** [https://publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/4207.htm](https://publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/4207.htm) - Status: 403 (line 58)
- [ ] **LINK** [https://publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/4207.htm](https://publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/4207.htm) - Status: 403 (line 58)

### reference\global-government-medical-research-spending.md

- [ ] **LINK** [https://www.kowi.de/en/kowi/Horizon-Europe/2324/health-demographic-change-and-wellbeing-2018-2020.aspx](https://www.kowi.de/en/kowi/Horizon-Europe/2324/health-demographic-change-and-wellbeing-2018-2020.aspx) - Status: 403 (line 79)
- [ ] **LINK** [https://www.fiercebiotech.com/research/report-every-dollar-nih-research-funding-doubles-economic-returns](https://www.fiercebiotech.com/research/report-every-dollar-nih-research-funding-doubles-economic-returns) - Status: 403 (line 119)

### reference\existing-dct-platforms.md

- [ ] **LINK** [https://www.science37.com/](https://www.science37.com/) - Status: 403 (line 10)
- [ ] **LINK** [https://florencehc.com/](https://florencehc.com/) - Status: 403 (line 17)
- [ ] **LINK** [https://www.castoredc.com/](https://www.castoredc.com/) - Status: 403 (line 18)
- [ ] **LINK** [https://www.nanalyze.com/2021/06/science-37-stock-decentralized-clinical-trials/](https://www.nanalyze.com/2021/06/science-37-stock-decentralized-clinical-trials/) - Status: 403 (line 94)
- [ ] **LINK** [https://www.science37.com/sites/default/files/2022-07/S37_WhitePaper_AnExecClinicalTrialPlaybook_July2022.pdf](https://www.science37.com/sites/default/files/2022-07/S37_WhitePaper_AnExecClinicalTrialPlaybook_July2022.pdf) - Status: 403 (line 95)
- [ ] **LINK** [https://www.fiercebiotech.com/cro/decentralized-studies-offer-financial-benefits-says-new-study](https://www.fiercebiotech.com/cro/decentralized-studies-offer-financial-benefits-says-new-study) - Status: 403 (line 100)
- [ ] **LINK** [https://www.drugdiscoverytrends.com/decentralized-clinical-trials-can-have-big-financial-upside-study-finds](https://www.drugdiscoverytrends.com/decentralized-clinical-trials-can-have-big-financial-upside-study-finds) - Status: 403 (line 100)
- [ ] **LINK** [https://www.fiercebiotech.com/cro/curavit-reaps-5m-series-funding-fuel-decentralized-trial-growth](https://www.fiercebiotech.com/cro/curavit-reaps-5m-series-funding-fuel-decentralized-trial-growth) - Status: 403 (line 105)
- [ ] **LINK** [https://florencehc.com/press-release/florence-healthcare-announces-27-million-series-c-1-round-led-by-high-growth-scaleup-investor-insight-partners/](https://florencehc.com/press-release/florence-healthcare-announces-27-million-series-c-1-round-led-by-high-growth-scaleup-investor-insight-partners/) - Status: 403 (line 118)
- [ ] **LINK** [https://florencehc.com/press-release/investment-in-site-enablement-to-accelerate-research-grows-300-florence-healthcare-releases-state-of-clinical-trial-technology-report/](https://florencehc.com/press-release/investment-in-site-enablement-to-accelerate-research-grows-300-florence-healthcare-releases-state-of-clinical-trial-technology-report/) - Status: 403 (line 119)
- [ ] **LINK** [https://www.castoredc.com/news/castor-raises-45m-series-b/](https://www.castoredc.com/news/castor-raises-45m-series-b/) - Status: 403 (line 121)
- [ ] **LINK** [https://www.castoredc.com/news/castor-named-2021-cb-insights-digital-health-150/](https://www.castoredc.com/news/castor-named-2021-cb-insights-digital-health-150/) - Status: 403 (line 122)

### reference\automatic-pill-dispensers.md

- [ ] **LINK** [https://www.retirementliving.com/automatic-pill-dispensers](https://www.retirementliving.com/automatic-pill-dispensers) - Status: 403 (line 120)

### reference\antidepressant-reviews.md

- [ ] **LINK** [https://www.askapatient.com/](https://www.askapatient.com/) - Status: 403 (line 4)
- [ ] **LINK** [https://www.askapatient.com/comparedrugs.asp?Class=ANTIDEPRESSANTS&SortBy=AvgOfSatisfaction&SortOrder=DESC](https://www.askapatient.com/comparedrugs.asp?Class=ANTIDEPRESSANTS&SortBy=AvgOfSatisfaction&SortOrder=DESC) - Status: 403 (line 21)

### reference\adaptive-platform-for-personalized-engagement.md

- [ ] **LINK** [https://careevolution.com/](https://careevolution.com/) - Status: 403 (line 387)

### problems\we-only-know-the-effects-of-0000000002-of-potential-therapies.md

- [ ] **LINK** [https://www.centerwatch.com/articles/12702-new-mit-study-puts-clinical-research-success-rate-at-14-percent](https://www.centerwatch.com/articles/12702-new-mit-study-puts-clinical-research-success-rate-at-14-percent) - Status: 403 (line 12)

### problems\we-know-nothing.md

- [ ] **LINK** [https://www.centerwatch.com/articles/12702-new-mit-study-puts-clinical-research-success-rate-at-14-percent](https://www.centerwatch.com/articles/12702-new-mit-study-puts-clinical-research-success-rate-at-14-percent) - Status: 403 (line 14)

### problems\problems-in-clinical-research.md

- [ ] **LINK** [https://www.centerwatch.com/articles/12702-new-mit-study-puts-clinical-research-success-rate-at-14-percent](https://www.centerwatch.com/articles/12702-new-mit-study-puts-clinical-research-success-rate-at-14-percent) - Status: 403 (line 36)

### problems\people-with-rare-disease-are-severely-punished.md

- [ ] **LINK** [https://rarediseases.org/wp-content/uploads/2019/01/RDD-FAQ-2019.pdf](https://rarediseases.org/wp-content/uploads/2019/01/RDD-FAQ-2019.pdf) - Status: 403 (line 8)
- [ ] **LINK** [https://rarediseases.org/understanding-rare-disease/rare-disease-facts-and-statistics/](https://rarediseases.org/understanding-rare-disease/rare-disease-facts-and-statistics/) - Status: 403 (line 11)

### problems\no-data-on-unpatentable-molecules.md

- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/assets/how-much-we-know%20%281%29%20%281%29%20%281%29.png](https://static.crowdsourcingcures.org/dfda/assets/how-much-we-know%20%281%29%20%281%29%20%281%29.png) - Status: 403 (line 6)
- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/assets/how-much-we-know%20%281%29%20%281%29%20%281%29.png](https://static.crowdsourcingcures.org/dfda/assets/how-much-we-know%20%281%29%20%281%29%20%281%29.png) - Status: 403 (line 6)

### problems\drug-lag.md

- [ ] **LINK** [https://www.fdareview.org/features/references/#gieringer85](https://www.fdareview.org/features/references/#gieringer85) - Status: 403 (line 15)
- [ ] **LINK** [https://www.fdareview.org/features/references/#wardell78a](https://www.fdareview.org/features/references/#wardell78a) - Status: 403 (line 17)
- [ ] **LINK** [https://www.fdareview.org/features/references/#gieringer85](https://www.fdareview.org/features/references/#gieringer85) - Status: 403 (line 17)

### problems\deaths-due-to-us-regulatory-drug-lag.md

- [ ] **LINK** [https://www.fdareview.org/features/references/#gieringer85](https://www.fdareview.org/features/references/#gieringer85) - Status: 403 (line 10)
- [ ] **LINK** [https://www.fdareview.org/features/references/#wardell78a](https://www.fdareview.org/features/references/#wardell78a) - Status: 403 (line 12)
- [ ] **LINK** [https://www.fdareview.org/features/references/#gieringer85](https://www.fdareview.org/features/references/#gieringer85) - Status: 403 (line 12)

### problems\clinical-research-is-expensive.md

- [ ] **LINK** [https://www.businesswire.com/news/home/20220113005740/en/New-Study-Decentralized-Clinical-Trials-Can-Achieve-Net-Financial-Benefits-of-5X-to-14X-Due-to-Reduced-Trial-Timelines-and-Other-Factors](https://www.businesswire.com/news/home/20220113005740/en/New-Study-Decentralized-Clinical-Trials-Can-Achieve-Net-Financial-Benefits-of-5X-to-14X-Due-to-Reduced-Trial-Timelines-and-Other-Factors) - Status: 403 (line 9)

### interventions\tranylcypromine-parnate.md

- [ ] **LINK** [https://maoinhibitors.com/augmenting-mao-inhibitors/](https://maoinhibitors.com/augmenting-mao-inhibitors/) - Status: 403 (line 30)
- [ ] **LINK** [https://maoinhibitors.com/l-tryptophan-serotonin-syndrome/](https://maoinhibitors.com/l-tryptophan-serotonin-syndrome/) - Status: 403 (line 30)
- [ ] **LINK** [https://maoinhibitors.com/serious-risks/](https://maoinhibitors.com/serious-risks/) - Status: 403 (line 32)
- [ ] **LINK** [https://maoinhibitors.com/augmenting-mao-inhibitors/](https://maoinhibitors.com/augmenting-mao-inhibitors/) - Status: 403 (line 54)
- [ ] **LINK** [https://maoinhibitors.com/l-tryptophan-serotonin-syndrome/](https://maoinhibitors.com/l-tryptophan-serotonin-syndrome/) - Status: 403 (line 54)
- [ ] **LINK** [https://maoinhibitors.com/serious-risks/](https://maoinhibitors.com/serious-risks/) - Status: 403 (line 56)
- [ ] **LINK** [https://studies.crowdsourcingcures.org/study/cause-6066179-effect-1398-user-230-user-study](https://studies.crowdsourcingcures.org/study/cause-6066179-effect-1398-user-230-user-study) - Status: 403 (line 155)
- [ ] **LINK** [https://maoinhibitors.com/community/parnate-tranylcypromine/](https://maoinhibitors.com/community/parnate-tranylcypromine/) - Status: 403 (line 169)
- [ ] **LINK** [https://maoinhibitors.com/](https://maoinhibitors.com/) - Status: 403 (line 267)

### interventions\parnate.md

- [ ] **LINK** [https://maoinhibitors.com/augmenting-mao-inhibitors/](https://maoinhibitors.com/augmenting-mao-inhibitors/) - Status: 403 (line 30)
- [ ] **LINK** [https://maoinhibitors.com/l-tryptophan-serotonin-syndrome/](https://maoinhibitors.com/l-tryptophan-serotonin-syndrome/) - Status: 403 (line 30)
- [ ] **LINK** [https://maoinhibitors.com/serious-risks/](https://maoinhibitors.com/serious-risks/) - Status: 403 (line 32)
- [ ] **LINK** [https://maoinhibitors.com/augmenting-mao-inhibitors/](https://maoinhibitors.com/augmenting-mao-inhibitors/) - Status: 403 (line 54)
- [ ] **LINK** [https://maoinhibitors.com/l-tryptophan-serotonin-syndrome/](https://maoinhibitors.com/l-tryptophan-serotonin-syndrome/) - Status: 403 (line 54)
- [ ] **LINK** [https://maoinhibitors.com/serious-risks/](https://maoinhibitors.com/serious-risks/) - Status: 403 (line 56)
- [ ] **LINK** [https://maoinhibitors.com/community/augmenting-regimens/is-l-tyrosine-supplementation-ever-safe-or-desirable/](https://maoinhibitors.com/community/augmenting-regimens/is-l-tyrosine-supplementation-ever-safe-or-desirable/) - Status: 403 (line 98)
- [ ] **LINK** [https://studies.dfda.earth/study/cause-6066179-effect-1398-user-230-user-study](https://studies.dfda.earth/study/cause-6066179-effect-1398-user-230-user-study) - Status: 403 (line 154)
- [ ] **LINK** [https://maoinhibitors.com/community/parnate-tranylcypromine/](https://maoinhibitors.com/community/parnate-tranylcypromine/) - Status: 403 (line 168)
- [ ] **LINK** [https://maoinhibitors.com/](https://maoinhibitors.com/) - Status: 403 (line 266)

### interventions\larazotide-acetate.md

- [ ] **LINK** [https://www.peptidesciences.com/gut-inflammation-research-formula](https://www.peptidesciences.com/gut-inflammation-research-formula) - Status: 403 (line 33)

### interventions\isrib-integrated-stress-response-inhibitor.md

- [ ] **LINK** [https://www.isrib.shop/](https://www.isrib.shop/) - Status: 429 (line 184)
- [ ] **LINK** [https://focusbiomolecules.com/isrib-integrated-stress-response-inhibitor/](https://focusbiomolecules.com/isrib-integrated-stress-response-inhibitor/) - Status: 403 (line 190)

### interventions\faah-out-mutation.md

- [ ] **LINK** [https://www.biologyonline.com/articles/faah-out-mutation-for-a-life-of-no-pain-no-faah-no-pain](https://www.biologyonline.com/articles/faah-out-mutation-for-a-life-of-no-pain-no-faah-no-pain) - Status: 403 (line 4)
- [ ] **LINK** [https://www.biologyonline.com/articles/faah-out-mutation-for-a-life-of-no-pain-no-faah-no-pain](https://www.biologyonline.com/articles/faah-out-mutation-for-a-life-of-no-pain-no-faah-no-pain) - Status: 403 (line 4)
- [ ] **LINK** [https://www.scotsman.com/regions/scottish-woman-gene-mutation-feels-no-pain-1421088](https://www.scotsman.com/regions/scottish-woman-gene-mutation-feels-no-pain-1421088) - Status: 403 (line 172)

### interventions\adderall.md

- [ ] **LINK** [http://www.iherb.com/Doctor-s-Best-Magnesium-High-Absorption-100-Chelated-120-Tablets/15?rcode=xon237](http://www.iherb.com/Doctor-s-Best-Magnesium-High-Absorption-100-Chelated-120-Tablets/15?rcode=xon237) - Status: 403 (line 15)
- [ ] **LINK** [http://www.iherb.com/doctor-s-best-best-stabilized-r-lipoic-acid-100-mg-60-veggie-caps/4?rcode=xon237](http://www.iherb.com/doctor-s-best-best-stabilized-r-lipoic-acid-100-mg-60-veggie-caps/4?rcode=xon237) - Status: 403 (line 17)
- [ ] **LINK** [http://www.iherb.com/now-foods-l-theanine-double-strength-200-mg-60-vcaps/6916?rcode=xon237](http://www.iherb.com/now-foods-l-theanine-double-strength-200-mg-60-vcaps/6916?rcode=xon237) - Status: 403 (line 21)
- [ ] **LINK** [http://www.iherb.com/Doctor-s-Best-Magnesium-High-Absorption-100-Chelated-120-Tablets/15?rcode=xon237](http://www.iherb.com/Doctor-s-Best-Magnesium-High-Absorption-100-Chelated-120-Tablets/15?rcode=xon237) - Status: 403 (line 39)
- [ ] **LINK** [http://www.iherb.com/doctor-s-best-best-stabilized-r-lipoic-acid-100-mg-60-veggie-caps/4?rcode=xon237](http://www.iherb.com/doctor-s-best-best-stabilized-r-lipoic-acid-100-mg-60-veggie-caps/4?rcode=xon237) - Status: 403 (line 44)
- [ ] **LINK** [http://www.iherb.com/rainbow-light-gummy-vitamin-c-slices-tangy-tangerine-flavor-90-gummies/40005?rcode=xon237](http://www.iherb.com/rainbow-light-gummy-vitamin-c-slices-tangy-tangerine-flavor-90-gummies/40005?rcode=xon237) - Status: 403 (line 52)

### features\predictor-search-engine.md

- [ ] **LINK** [https://app.quantimo.do/variables/Overall%20Mood](https://app.quantimo.do/variables/Overall%20Mood) - Status: 403 (line 13)
- [ ] **LINK** [https://app.quantimo.do/variables/Overall%20Mood](https://app.quantimo.do/variables/Overall%20Mood) - Status: 403 (line 33)
- [ ] **LINK** [https://app.quantimo.do/variables/Overall%20Mood](https://app.quantimo.do/variables/Overall%20Mood) - Status: 403 (line 39)
- [ ] **LINK** [https://app.quantimo.do/variables/Overall%20Mood](https://app.quantimo.do/variables/Overall%20Mood) - Status: 403 (line 45)

### features\personal-fda-nodes.md

- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/components/digital-twin-safe/digital-twin-safe.jpg](https://static.crowdsourcingcures.org/dfda/components/digital-twin-safe/digital-twin-safe.jpg) - Status: 403 (line 9)
- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/components/digital-twin-safe/digital-twin-safe.jpg](https://static.crowdsourcingcures.org/dfda/components/digital-twin-safe/digital-twin-safe.jpg) - Status: 403 (line 9)

### features\outcome-labels.md

- [ ] **IMAGE** [https://crowdsourcingcures.org/wp-content/uploads/2021/05/nutrition-facts-vs-outcome-labels-melatonin-1024x592.png](https://crowdsourcingcures.org/wp-content/uploads/2021/05/nutrition-facts-vs-outcome-labels-melatonin-1024x592.png) - Status: 403 (line 16)
- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/components/outcome-labels/broccoli-inflammation.png](https://static.crowdsourcingcures.org/dfda/components/outcome-labels/broccoli-inflammation.png) - Status: 403 (line 25)
- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/components/outcome-labels/broccoli-inflammation.png](https://static.crowdsourcingcures.org/dfda/components/outcome-labels/broccoli-inflammation.png) - Status: 403 (line 25)
- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/components/outcome-labels/broccoli-depression.png](https://static.crowdsourcingcures.org/dfda/components/outcome-labels/broccoli-depression.png) - Status: 403 (line 29)
- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/components/outcome-labels/broccoli-depression.png](https://static.crowdsourcingcures.org/dfda/components/outcome-labels/broccoli-depression.png) - Status: 403 (line 29)
- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/components/outcome-labels/melatonin-sleep-quality.png](https://static.crowdsourcingcures.org/dfda/components/outcome-labels/melatonin-sleep-quality.png) - Status: 403 (line 36)
- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/components/outcome-labels/melatonin-sleep-quality.png](https://static.crowdsourcingcures.org/dfda/components/outcome-labels/melatonin-sleep-quality.png) - Status: 403 (line 36)
- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/components/outcome-labels/melatonin-drowsiness.png](https://static.crowdsourcingcures.org/dfda/components/outcome-labels/melatonin-drowsiness.png) - Status: 403 (line 40)
- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/components/outcome-labels/melatonin-drowsiness.png](https://static.crowdsourcingcures.org/dfda/components/outcome-labels/melatonin-drowsiness.png) - Status: 403 (line 40)
- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/components/outcome-labels/sugar-blood-sugar.png](https://static.crowdsourcingcures.org/dfda/components/outcome-labels/sugar-blood-sugar.png) - Status: 403 (line 47)
- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/components/outcome-labels/sugar-blood-sugar.png](https://static.crowdsourcingcures.org/dfda/components/outcome-labels/sugar-blood-sugar.png) - Status: 403 (line 47)
- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/components/outcome-labels/sugar-energy-levels.png](https://static.crowdsourcingcures.org/dfda/components/outcome-labels/sugar-energy-levels.png) - Status: 403 (line 51)
- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/components/outcome-labels/sugar-energy-levels.png](https://static.crowdsourcingcures.org/dfda/components/outcome-labels/sugar-energy-levels.png) - Status: 403 (line 51)

### features\outcome-labels-plugin.md

- [ ] **IMAGE** [https://crowdsourcingcures.org/wp-content/uploads/2021/02/nutrition-label-436x1024-1.jpg](https://crowdsourcingcures.org/wp-content/uploads/2021/02/nutrition-label-436x1024-1.jpg) - Status: 403 (line 6)
- [ ] **IMAGE** [https://crowdsourcingcures.org/wp-content/uploads/2021/05/nutrition-facts-vs-outcome-labels-melatonin-1024x592.png](https://crowdsourcingcures.org/wp-content/uploads/2021/05/nutrition-facts-vs-outcome-labels-melatonin-1024x592.png) - Status: 403 (line 14)
- [ ] **IMAGE** [https://crowdsourcingcures.org/wp-content/uploads/2021/03/johnny-5-need-input.gif](https://crowdsourcingcures.org/wp-content/uploads/2021/03/johnny-5-need-input.gif) - Status: 403 (line 22)

### features\optomitron-real-time-notifications-plugin.md

- [ ] **LINK** [https://keep.lib.asu.edu/_flysystem/fedora/c7/114023/Deshpande_asu_0010E_14022.pdf](https://keep.lib.asu.edu/_flysystem/fedora/c7/114023/Deshpande_asu_0010E_14022.pdf) - Status: 403 (line 146)

### features\notifications.md

- [ ] **LINK** [https://github.com/FDA-AI/FDAi/tree/develop/apps/dfda-1/app/PhpUnitJobs/Reminders/PushNotificationsJob.php](https://github.com/FDA-AI/FDAi/tree/develop/apps/dfda-1/app/PhpUnitJobs/Reminders/PushNotificationsJob.php) - Status: 429 (line 13)

### features\digital-twin-safe.md

- [ ] **LINK** [https://www.crunchbase.com/organization/lit-protocol](https://www.crunchbase.com/organization/lit-protocol) - Status: 403 (line 86)
- [ ] **LINK** [https://www.coindesk.com/business/2022/09/22/cryptography-network-lit-protocol-raises-13m-to-bolster-web3-autonomy-and-interoperability/](https://www.coindesk.com/business/2022/09/22/cryptography-network-lit-protocol-raises-13m-to-bolster-web3-autonomy-and-interoperability/) - Status: 429 (line 87)
- [ ] **LINK** [https://www.theblock.co/post/218089/ceramic-releases-tool-that-awakens-its-storage-for-web3-protocol](https://www.theblock.co/post/218089/ceramic-releases-tool-that-awakens-its-storage-for-web3-protocol) - Status: 403 (line 90)

### features\decision-support-notifications.md

- [ ] **LINK** [https://keep.lib.asu.edu/\_flysystem/fedora/c7/114023/Deshpande\_asu\_0010E\_14022.pdf](https://keep.lib.asu.edu/\_flysystem/fedora/c7/114023/Deshpande\_asu\_0010E\_14022.pdf) - Status: 403 (line 20)

### features\data-silo-api-gateways.md

- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/components/data-silo-gateway-api-nodes/dfda-gateway-api-node-silo.jpg](https://static.crowdsourcingcures.org/dfda/components/data-silo-gateway-api-nodes/dfda-gateway-api-node-silo.jpg) - Status: 403 (line 3)
- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/components/data-silo-gateway-api-nodes/dfda-gateway-api-node-silo.jpg](https://static.crowdsourcingcures.org/dfda/components/data-silo-gateway-api-nodes/dfda-gateway-api-node-silo.jpg) - Status: 403 (line 3)

### features\data-import.md

- [ ] **LINK** [https://github.com/FDA-AI/FDAi/tree/develop/apps/dfda-1/app/DataSources/Connectors/GithubConnector.php](https://github.com/FDA-AI/FDAi/tree/develop/apps/dfda-1/app/DataSources/Connectors/GithubConnector.php) - Status: 429 (line 16)

### economic-models\quantitative-value-medical-treatment.md

- [ ] **LINK** [https://bmjopen.bmj.com/content/2/3/e000752](https://bmjopen.bmj.com/content/2/3/e000752) - Status: 403 (line 49)

### economic-models\nih-grant-efficiency-analysis.md

- [ ] **LINK** [https://www.fdareview.org/features/references/#gieringer85](https://www.fdareview.org/features/references/#gieringer85) - Status: 403 (line 28)
- [ ] **LINK** [https://www.fdareview.org/features/references/#gieringer85](https://www.fdareview.org/features/references/#gieringer85) - Status: 403 (line 83)

### economic-models\intervention-comparison-table.md

- [ ] **LINK** [https://www.wateraid.org/us/media/economic-report-unlock-trillions-of-dollars-with-clean-water-decent-toilets-and-hygiene](https://www.wateraid.org/us/media/economic-report-unlock-trillions-of-dollars-with-clean-water-decent-toilets-and-hygiene) - Status: 403 (line 17)
- [ ] **LINK** [https://www.wateraid.org/us/media/economic-report-unlock-trillions-of-dollars-with-clean-water-decent-toilets-and-hygiene](https://www.wateraid.org/us/media/economic-report-unlock-trillions-of-dollars-with-clean-water-decent-toilets-and-hygiene) - Status: 403 (line 17)
- [ ] **LINK** [https://www.wateraid.org/us/media/economic-report-unlock-trillions-of-dollars-with-clean-water-decent-toilets-and-hygiene](https://www.wateraid.org/us/media/economic-report-unlock-trillions-of-dollars-with-clean-water-decent-toilets-and-hygiene) - Status: 403 (line 51)

### economic-models\dfda-cost-benefit-analysis.md

- [ ] **LINK** [https://www.commonwealthfund.org/publications/issue-briefs/2017/oct/paying-prescription-drugs-around-world-why-us-outlier](https://www.commonwealthfund.org/publications/issue-briefs/2017/oct/paying-prescription-drugs-around-world-why-us-outlier) - Status: 403 (line 361)
- [ ] **LINK** [https://www.commonwealthfund.org/publications/issue-briefs/2017/oct/paying-prescription-drugs-around-world-why-us-outlier](https://www.commonwealthfund.org/publications/issue-briefs/2017/oct/paying-prescription-drugs-around-world-why-us-outlier) - Status: 403 (line 365)
- [ ] **LINK** [https://www.commonwealthfund.org/publications/issue-briefs/2017/oct/paying-prescription-drugs-around-world-why-us-outlier](https://www.commonwealthfund.org/publications/issue-briefs/2017/oct/paying-prescription-drugs-around-world-why-us-outlier) - Status: 403 (line 1101)
- [ ] **LINK** [https://www.commonwealthfund.org/publications/issue-briefs/2017/oct/paying-prescription-drugs-around-world-why-us-outlier](https://www.commonwealthfund.org/publications/issue-briefs/2017/oct/paying-prescription-drugs-around-world-why-us-outlier) - Status: 403 (line 1132)

### economic-models\benefits-of-over-the-counter-classification.md

- [ ] **LINK** [https://www.chpa.org/sites/default/files/media/docs/2020-10/Potential-Reduction-Unnecessary-Visits-Doctors-from-Safe-Appropriate-Use-OTC-Medicines-Could%20Save-Billions-Annually-06172011.pdf#:~:text=primary%20care%20physicians,saw%20a%20doctor%20was%20%24199](https://www.chpa.org/sites/default/files/media/docs/2020-10/Potential-Reduction-Unnecessary-Visits-Doctors-from-Safe-Appropriate-Use-OTC-Medicines-Could%20Save-Billions-Annually-06172011.pdf#:~:text=primary%20care%20physicians,saw%20a%20doctor%20was%20%24199) - Status: 403 (line 40)
- [ ] **LINK** [https://www.chpa.org/sites/default/files/media/docs/2020-10/Potential-Reduction-Unnecessary-Visits-Doctors-from-Safe-Appropriate-Use-OTC-Medicines-Could%20Save-Billions-Annually-06172011.pdf#:~:text=-primary-care-physicians-2](https://www.chpa.org/sites/default/files/media/docs/2020-10/Potential-Reduction-Unnecessary-Visits-Doctors-from-Safe-Appropriate-Use-OTC-Medicines-Could%20Save-Billions-Annually-06172011.pdf#:~:text=-primary-care-physicians-2) - Status: 403 (line 56)
- [ ] **LINK** [https://www.chpa.org/sites/default/files/media/docs/2020-10/Potential-Reduction-Unnecessary-Visits-Doctors-from-Safe-Appropriate-Use-OTC-Medicines-Could%20Save-Billions-Annually-06172011.pdf#:~:text=-primary-care-physicians-2](https://www.chpa.org/sites/default/files/media/docs/2020-10/Potential-Reduction-Unnecessary-Visits-Doctors-from-Safe-Appropriate-Use-OTC-Medicines-Could%20Save-Billions-Annually-06172011.pdf#:~:text=-primary-care-physicians-2) - Status: 403 (line 56)
- [ ] **LINK** [https://www.chpa.org/sites/default/files/media/docs/2020-10/Potential-Reduction-Unnecessary-Visits-Doctors-from-Safe-Appropriate-Use-OTC-Medicines-Could%20Save-Billions-Annually-06172011.pdf#:~:text=primary%20care%20physicians,saw%20a%20doctor%20was%20%24199](https://www.chpa.org/sites/default/files/media/docs/2020-10/Potential-Reduction-Unnecessary-Visits-Doctors-from-Safe-Appropriate-Use-OTC-Medicines-Could%20Save-Billions-Annually-06172011.pdf#:~:text=primary%20care%20physicians,saw%20a%20doctor%20was%20%24199) - Status: 403 (line 56)
- [ ] **LINK** [https://www.chpa.org/sites/default/files/media/docs/2020-10/Potential-Reduction-Unnecessary-Visits-Doctors-from-Safe-Appropriate-Use-OTC-Medicines-Could%20Save-Billions-Annually-06172011.pdf#:~:text=including%20%2428%20in%20out,would%20save%20overburdened%20doctors%20almost](https://www.chpa.org/sites/default/files/media/docs/2020-10/Potential-Reduction-Unnecessary-Visits-Doctors-from-Safe-Appropriate-Use-OTC-Medicines-Could%20Save-Billions-Annually-06172011.pdf#:~:text=including%20%2428%20in%20out,would%20save%20overburdened%20doctors%20almost) - Status: 403 (line 56)
- [ ] **LINK** [https://www.chpa.org/sites/default/files/media/docs/2020-10/Potential-Reduction-Unnecessary-Visits-Doctors-from-Safe-Appropriate-Use-OTC-Medicines-Could%20Save-Billions-Annually-06172011.pdf#:~:text=medicines-it-would-save-consumerswould-save-overburdened-doctors-almost](https://www.chpa.org/sites/default/files/media/docs/2020-10/Potential-Reduction-Unnecessary-Visits-Doctors-from-Safe-Appropriate-Use-OTC-Medicines-Could%20Save-Billions-Annually-06172011.pdf#:~:text=medicines-it-would-save-consumerswould-save-overburdened-doctors-almost) - Status: 403 (line 66)
- [ ] **LINK** [https://www.americanprogress.org/article/excess-administrative-costs-burden-u-s-health-care-system/#:~:text=billion-in-2009—about-$466-billion14](https://www.americanprogress.org/article/excess-administrative-costs-burden-u-s-health-care-system/#:~:text=billion-in-2009—about-$466-billion14) - Status: 403 (line 75)
- [ ] **LINK** [https://www.americanprogress.org/article/excess-administrative-costs-burden-u-s-health-care-system/#:~:text=each-year-health-care-payersannually-according-to-cap’s-calculations](https://www.americanprogress.org/article/excess-administrative-costs-burden-u-s-health-care-system/#:~:text=each-year-health-care-payersannually-according-to-cap’s-calculations) - Status: 403 (line 75)
- [ ] **LINK** [https://www.chpa.org/sites/default/files/media/docs/2020-10/Potential-Reduction-Unnecessary-Visits-Doctors-from-Safe-Appropriate-Use-OTC-Medicines-Could%20Save-Billions-Annually-06172011.pdf#:~:text=including%20%2428%20in%20out,would%20save%20overburdened%20doctors%20almost](https://www.chpa.org/sites/default/files/media/docs/2020-10/Potential-Reduction-Unnecessary-Visits-Doctors-from-Safe-Appropriate-Use-OTC-Medicines-Could%20Save-Billions-Annually-06172011.pdf#:~:text=including%20%2428%20in%20out,would%20save%20overburdened%20doctors%20almost) - Status: 403 (line 140)
- [ ] **LINK** [https://www.chpa.org/sites/default/files/media/docs/2020-10/Potential-Reduction-Unnecessary-Visits-Doctors-from-Safe-Appropriate-Use-OTC-Medicines-Could%20Save-Billions-Annually-06172011.pdf#:~:text=including%20%2428%20in%20out,would%20save%20overburdened%20doctors%20almost](https://www.chpa.org/sites/default/files/media/docs/2020-10/Potential-Reduction-Unnecessary-Visits-Doctors-from-Safe-Appropriate-Use-OTC-Medicines-Could%20Save-Billions-Annually-06172011.pdf#:~:text=including%20%2428%20in%20out,would%20save%20overburdened%20doctors%20almost) - Status: 403 (line 140)
- [ ] **LINK** [https://www.chpa.org/sites/default/files/media/docs/2020-10/Potential-Reduction-Unnecessary-Visits-Doctors-from-Safe-Appropriate-Use-OTC-Medicines-Could%20Save-Billions-Annually-06172011.pdf#:~:text=medicines-it-would-save-consumerswould-save-overburdened-doctors-almost](https://www.chpa.org/sites/default/files/media/docs/2020-10/Potential-Reduction-Unnecessary-Visits-Doctors-from-Safe-Appropriate-Use-OTC-Medicines-Could%20Save-Billions-Annually-06172011.pdf#:~:text=medicines-it-would-save-consumerswould-save-overburdened-doctors-almost) - Status: 403 (line 160)
- [ ] **LINK** [https://www.chpa.org/sites/default/files/media/docs/2020-10/Potential-Reduction-Unnecessary-Visits-Doctors-from-Safe-Appropriate-Use-OTC-Medicines-Could%20Save-Billions-Annually-06172011.pdf#:~:text=-primary-care-physicians-2](https://www.chpa.org/sites/default/files/media/docs/2020-10/Potential-Reduction-Unnecessary-Visits-Doctors-from-Safe-Appropriate-Use-OTC-Medicines-Could%20Save-Billions-Annually-06172011.pdf#:~:text=-primary-care-physicians-2) - Status: 403 (line 173)
- [ ] **LINK** [https://www.chpa.org/sites/default/files/media/docs/2020-10/Potential-Reduction-Unnecessary-Visits-Doctors-from-Safe-Appropriate-Use-OTC-Medicines-Could%20Save-Billions-Annually-06172011.pdf#:~:text=-the-average-total-paymentsaw-a-doctor-was-$199](https://www.chpa.org/sites/default/files/media/docs/2020-10/Potential-Reduction-Unnecessary-Visits-Doctors-from-Safe-Appropriate-Use-OTC-Medicines-Could%20Save-Billions-Annually-06172011.pdf#:~:text=-the-average-total-paymentsaw-a-doctor-was-$199) - Status: 403 (line 173)
- [ ] **LINK** [https://www.americanprogress.org/article/excess-administrative-costs-burden-u-s-health-care-system/#:~:text=each-year-health-care-payersannually-according-to-cap’s-calculations](https://www.americanprogress.org/article/excess-administrative-costs-burden-u-s-health-care-system/#:~:text=each-year-health-care-payersannually-according-to-cap’s-calculations) - Status: 403 (line 187)
- [ ] **LINK** [https://www.americanprogress.org/article/excess-administrative-costs-burden-u-s-health-care-system/#:~:text=billion-in-2009—about-$466-billion14](https://www.americanprogress.org/article/excess-administrative-costs-burden-u-s-health-care-system/#:~:text=billion-in-2009—about-$466-billion14) - Status: 403 (line 187)

### conditions\scabies.md

- [ ] **LINK** [https://www.goodrx.com/ivermectin-non-prescription/what-is](https://www.goodrx.com/ivermectin-non-prescription/what-is) - Status: 403 (line 7)

### conditions\dementia-society-of-america.md

- [ ] **LINK** [https://crowdsourcingcures.org/open-epidemiology/](https://crowdsourcingcures.org/open-epidemiology/) - Status: 403 (line 20)

### community\open-source.md

- [ ] **LINK** [https://standardhealthrecord.org/](https://standardhealthrecord.org/) - Status: 403 (line 7)
- [ ] **LINK** [https://crowdsourcingcures.org/?swcfpc=1](https://crowdsourcingcures.org/?swcfpc=1) - Status: 403 (line 10)

### clinical-trials\open-humans.md

- [ ] **LINK** [https://crowdsourcingcures.org/outcome-labels/](https://crowdsourcingcures.org/outcome-labels/) - Status: 403 (line 67)

### benefits\cost-savings-from-decentralized-clinical-trials.md

- [ ] **LINK** [https://www.businesswire.com/news/home/20220113005740/en/New-Study-Decentralized-Clinical-Trials-Can-Achieve-Net-Financial-Benefits-of-5X-to-14X-Due-to-Reduced-Trial-Timelines-and-Other-Factors](https://www.businesswire.com/news/home/20220113005740/en/New-Study-Decentralized-Clinical-Trials-Can-Achieve-Net-Financial-Benefits-of-5X-to-14X-Due-to-Reduced-Trial-Timelines-and-Other-Factors) - Status: 403 (line 4)
- [ ] **LINK** [https://www.businesswire.com/news/home/20220113005740/en/New-Study-Decentralized-Clinical-Trials-Can-Achieve-Net-Financial-Benefits-of-5X-to-14X-Due-to-Reduced-Trial-Timelines-and-Other-Factors](https://www.businesswire.com/news/home/20220113005740/en/New-Study-Decentralized-Clinical-Trials-Can-Achieve-Net-Financial-Benefits-of-5X-to-14X-Due-to-Reduced-Trial-Timelines-and-Other-Factors) - Status: 403 (line 5)
- [ ] **LINK** [https://www.businesswire.com/news/home/20220113005740/en/New-Study-Decentralized-Clinical-Trials-Can-Achieve-Net-Financial-Benefits-of-5X-to-14X-Due-to-Reduced-Trial-Timelines-and-Other-Factors](https://www.businesswire.com/news/home/20220113005740/en/New-Study-Decentralized-Clinical-Trials-Can-Achieve-Net-Financial-Benefits-of-5X-to-14X-Due-to-Reduced-Trial-Timelines-and-Other-Factors) - Status: 403 (line 6)

### act\act-details.md

- [ ] **LINK** [https://everycure.org/the-problem/](https://everycure.org/the-problem/) - Status: 403 (line 45)
- [ ] **LINK** [https://everycure.org/the-problem/](https://everycure.org/the-problem/) - Status: 403 (line 318)

### wiki\open-source\open-health-standards.md

- [ ] **LINK** [http://standardhealthrecord.org/](http://standardhealthrecord.org/) - Status: 403 (line 36)

### problems\statistics\years-since-last-cure.md

- [ ] **LINK** [https://www.cbo.gov/publication/57126](https://www.cbo.gov/publication/57126) - Status: 403 (line 10)
- [ ] **LINK** [https://www.cbo.gov/publication/57126](https://www.cbo.gov/publication/57126) - Status: 403 (line 12)
- [ ] **LINK** [https://www.cbo.gov/publication/57126](https://www.cbo.gov/publication/57126) - Status: 403 (line 14)

### problems\statistics\treatments-tested.md

- [ ] **LINK** [https://www.centerwatch.com/articles/12702-new-mit-study-puts-clinical-research-success-rate-at-14-percent](https://www.centerwatch.com/articles/12702-new-mit-study-puts-clinical-research-success-rate-at-14-percent) - Status: 403 (line 11)

### problems\statistics\deaths-due-to-drug-lag.md

- [ ] **LINK** [https://www.fdareview.org/features/references/#gieringer85](https://www.fdareview.org/features/references/#gieringer85) - Status: 403 (line 2)
- [ ] **LINK** [https://www.fdareview.org/features/references/#gieringer85](https://www.fdareview.org/features/references/#gieringer85) - Status: 403 (line 11)

### problems\statistics\cost-per-treatment.md

- [ ] **LINK** [https://www.genengnews.com/gen-edge/the-unbearable-cost-of-drug-development-deloitte-report-shows-15-jump-in-rd-to-2-3-billion/](https://www.genengnews.com/gen-edge/the-unbearable-cost-of-drug-development-deloitte-report-shows-15-jump-in-rd-to-2-3-billion/) - Status: 403 (line 4)

### problems\statistics\cost-per-participant.md

- [ ] **LINK** [https://clinicalresearch.io/blog/running-a-study/cost-of-clinical-trials-breakdown/](https://clinicalresearch.io/blog/running-a-study/cost-of-clinical-trials-breakdown/) - Status: 403 (line 1)

### features\fdai\fdai.md

- [ ] **IMAGE** [https://static.crowdsourcingcures.org/img/frequency-analysis-300x225.gif](https://static.crowdsourcingcures.org/img/frequency-analysis-300x225.gif) - Status: 403 (line 37)

### features\clinipedia\clinipedia.md

- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/components/clinipedia/clinipedia_globe_circle.jpg](https://static.crowdsourcingcures.org/dfda/components/clinipedia/clinipedia_globe_circle.jpg) - Status: 403 (line 3)
- [ ] **LINK** [https://static.crowdsourcingcures.org/dfda/components/clinipedia/clinipedia_globe_circle.jpg](https://static.crowdsourcingcures.org/dfda/components/clinipedia/clinipedia_globe_circle.jpg) - Status: 403 (line 3)
- [ ] **LINK** [https://crowdsourcingcures.org/](https://crowdsourcingcures.org/) - Status: 403 (line 22)

### community\nonprofits\every-cure.md

- [ ] **LINK** [https://everycure.org/](https://everycure.org/) - Status: 403 (line 47)

### community\nonprofits\crowdsourcing-cures.md

- [ ] **IMAGE** [https://crowdsourcingcures.org/wp-content/uploads/2020/09/brain-diseases-1.png](https://crowdsourcingcures.org/wp-content/uploads/2020/09/brain-diseases-1.png) - Status: 403 (line 4)
- [ ] **IMAGE** [https://crowdsourcingcures.org/wp-content/uploads/2020/09/costs-of-mental-illness-edited-1.png](https://crowdsourcingcures.org/wp-content/uploads/2020/09/costs-of-mental-illness-edited-1.png) - Status: 403 (line 14)
- [ ] **IMAGE** [https://crowdsourcingcures.org/wp-content/uploads/2020/09/the-world-that-could-be-better-world-through-data-e1601509613410-1024x598.jpg](https://crowdsourcingcures.org/wp-content/uploads/2020/09/the-world-that-could-be-better-world-through-data-e1601509613410-1024x598.jpg) - Status: 403 (line 20)
- [ ] **IMAGE** [https://crowdsourcingcures.org/wp-content/uploads/2020/10/slow-research-transparent-2-1024x869.png](https://crowdsourcingcures.org/wp-content/uploads/2020/10/slow-research-transparent-2-1024x869.png) - Status: 403 (line 30)
- [ ] **IMAGE** [https://crowdsourcingcures.org/wp-content/uploads/2020/10/why-research-is-failing.png](https://crowdsourcingcures.org/wp-content/uploads/2020/10/why-research-is-failing.png) - Status: 403 (line 36)
- [ ] **IMAGE** [https://crowdsourcingcures.org/wp-content/uploads/2020/10/factors-1024x402.png](https://crowdsourcingcures.org/wp-content/uploads/2020/10/factors-1024x402.png) - Status: 403 (line 44)
- [ ] **IMAGE** [https://crowdsourcingcures.org/wp-content/uploads/2020/10/what-we-do-not-know.png](https://crowdsourcingcures.org/wp-content/uploads/2020/10/what-we-do-not-know.png) - Status: 403 (line 50)
- [ ] **IMAGE** [https://crowdsourcingcures.org/wp-content/uploads/2020/10/world-self-tracking-1024x451.png](https://crowdsourcingcures.org/wp-content/uploads/2020/10/world-self-tracking-1024x451.png) - Status: 403 (line 56)
- [ ] **IMAGE** [https://crowdsourcingcures.org/wp-content/uploads/2020/10/self-tracking-1024x395.png](https://crowdsourcingcures.org/wp-content/uploads/2020/10/self-tracking-1024x395.png) - Status: 403 (line 60)
- [ ] **IMAGE** [https://crowdsourcingcures.org/wp-content/uploads/2020/10/import-data-1024x535.png](https://crowdsourcingcures.org/wp-content/uploads/2020/10/import-data-1024x535.png) - Status: 403 (line 66)
- [ ] **IMAGE** [https://crowdsourcingcures.org/wp-content/uploads/2020/10/track-factors-1024x536.png](https://crowdsourcingcures.org/wp-content/uploads/2020/10/track-factors-1024x536.png) - Status: 403 (line 68)
- [ ] **IMAGE** [https://crowdsourcingcures.org/wp-content/uploads/2020/10/track-symptoms-2-1024x534.png](https://crowdsourcingcures.org/wp-content/uploads/2020/10/track-symptoms-2-1024x534.png) - Status: 403 (line 70)
- [ ] **IMAGE** [https://crowdsourcingcures.org/wp-content/uploads/2020/10/machine-learning-1024x408.png](https://crowdsourcingcures.org/wp-content/uploads/2020/10/machine-learning-1024x408.png) - Status: 403 (line 76)
- [ ] **IMAGE** [https://crowdsourcingcures.org/wp-content/uploads/2020/10/top-predictors.png](https://crowdsourcingcures.org/wp-content/uploads/2020/10/top-predictors.png) - Status: 403 (line 82)
- [ ] **IMAGE** [https://crowdsourcingcures.org/wp-content/uploads/2020/10/journal-of-citizen-science.png](https://crowdsourcingcures.org/wp-content/uploads/2020/10/journal-of-citizen-science.png) - Status: 403 (line 88)
- [ ] **IMAGE** [https://crowdsourcingcures.org/wp-content/uploads/2020/10/open-source-720x360-1.jpg](https://crowdsourcingcures.org/wp-content/uploads/2020/10/open-source-720x360-1.jpg) - Status: 403 (line 92)

## Error URLs

### reference\existing-dct-platforms.md

- [ ] **LINK** [https://clinical.labcorp.com/decentralized-clinical-trials.html](https://clinical.labcorp.com/decentralized-clinical-trials.html) - Error: fetch failed (line 16)

### community\open-source.md

- [ ] **LINK** [https://opensourcetimeline.com/](https://opensourcetimeline.com/) - Error: fetch failed (line 5)

### community\nonprofits\every-cure.md

- [ ] **LINK** [https://atlas.everycure.org/](https://atlas.everycure.org/) - Error: fetch failed (line 48)
